Paracrine signaling between tumor subclones of mouse sclc: A critical role of ets transcription factor pea3 in facilitating metastasis

Genes and Development

Volumn 29, Issue 15, 2015, Pages 1587-1592

  Kwon, Min Chul ^a   Proost, Natalie ^a   Song, Ji Ying ^a   Sutherland, Kate D ^a,c   Zevenhoven, John ^a   Berns, Anton ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Fgf2; Metastasis; Pea3; Small cell lung cancer; Tumor heterogeneity

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR PEA3; CULTURE MEDIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONAL EVOLUTION; HUMAN; HUMAN CELL; LIVER METASTASIS; MOLECULAR CLONING; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL CELL LUNG CANCER; TUMOR CELL; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; CULTURE MEDIUM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; METASTASIS; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

POLYOMAVIRUS;

ANIMALS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-ETS; SMALL CELL LUNG CARCINOMA; TRANSCRIPTION FACTORS;

EID: 84938850603     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.262998.115     Document Type: Article

References (35)

1. Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, Colman SM, Kempski H, Moorman AV, Titley I, Swansbury J, et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469: 356–361
2. Aytes A, Mitrofanova A, Kinkade CW, Lefebvre C, Lei M, Phelan V, LeKaye HC, Koutcher JA, Cardiff RD, Califano A, et al. 2013. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci 110: E3506–E3515
3. Brent AE, Tabin CJ. 2004. FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 131: 3885–3896
4. Burrell RA, Swanton C. 2014. Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol 8: 1095–1111
5. Calbo J, van Montfort E, Proost N, van Drunen E, Beverloo HB, Meuwissen R, Berns A. 2011. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19: 244–256
6. Corn PG, Wang F, McKeehan WL, Navone N. 2013. Targeting fibroblast growth factor pathways in prostate cancer. Clin Cancer Res 19: 5856–5866
7. D’Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B, Nagamine Y. 1997. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201: 179–187
8. Fidler IJ. 2003. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3: 453–458
9. Firnberg N, Neubuser A. 2002. FGF signaling regulates expression of Tbx2, Erm, Pea3, and Pax3 in the early nasal region. Dev Biol 247: 237–250
10. Hanahan D, Weinberg Robert A. 2011. Hallmarks of cancer: the next generation. Cell 144: 646–674
11. Hardy KM, Yatskievych TA, Konieczka J, Bobbs AS, Antin PB. 2011. FGF signalling through RAS/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression. BMC Dev Biol 11: 20
12. Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, Imai K. 2003. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 200: 568–576
13. Jackman DM, Johnson BE. 2005. Small-cell lung cancer. Lancet 366: 1385–1396
14. Junttila MR, de Sauvage FJ. 2013. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501: 346–354
15. Keld R, Guo B, Downey P, Cummins R, Gulmann C, Ang YS, Sharrocks AD. 2011. PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma. Br J Cancer 105: 124–130
16. Kwon MC, Berns A. 2013. Mouse models for lung cancer. Mol Oncol 7: 165–177
17. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Carducci MA, et al. 2009. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15: 559–565
18. Mao J, McGlinn E, Huang P, Tabin CJ, McMahon AP. 2009. Fgf-dependent Etv4/5 activity is required for posterior restriction of Sonic Hedgehog and promoting outgrowth of the vertebrate limb. Dev Cell 16: 600–606
19. McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Stewart C, Carter SL, Cibulskis K, Bhutkar A, McKenna A, Dooley A, Vernon A, et al. 2014. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 156: 1298–1311
20. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. 2003. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4: 181–189
21. Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, Ma J, Minden MD, Downing JR, Dick JE. 2011. Evolution of human BCRABL1 lymphoblastic leukaemia-initiating cells. Nature 469: 362–367
22. Oh S, Shin S, Janknecht R. 2012. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors. Biochim Biophys Acta 1826: 1–12
23. Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, et al. 2012. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44: 1104–1110
24. Raible F, Brand M. 2001. Tight transcriptional control of the ETS domain factors Erm and Pea3 by Fgf signaling during early zebrafish development. Mech Dev 107: 105–117
25. Ruotsalainen T, Joensuu H, Mattson K, Salven P. 2002. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer. Cancer Epidemiol Biomarkers Prev 11: 1492–1495
26. Sloan KA, Marquez HA, Li J, Cao Y, Hinds A, O’Hara CJ, Kathuria S, Ramirez MI, Williams MC, Kathuria H. 2009. Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCIH23 NSCLC cell lines. Carcinogenesis 30: 1433–1442
27. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM, DeClerck YA. 2012. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 72: 2473–2480
28. Turner N, Grose R. 2010. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10: 116–129
29. Valastyan S, Weinberg Robert A. 2011. Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275–292
30. van Meerbeeck JP, Fennell DA, De Ruysscher DK. 2011. Small-cell lung cancer. Lancet 378: 1741–1755
31. Wang Y, Becker D. 1997. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 3: 887–893
32. Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, Witt H, Croul S, Bouffet E, Fults DW, Eberhart CG, et al. 2012. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482: 529–533
33. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114–1117
34. Yuen HF, Chan YK, Grills C, McCrudden CM, Gunasekharan V, Shi Z, Wong AS, Lappin TR, Chan KW, Fennell DA, et al. 2011. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition. J Pathol 224: 78–89
35. Zhang Z, Verheyden JM, Hassell JA, Sun X. 2009. FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. Dev Cell 16: 607–613.